The 20th anniversary of interleukin-2 therapy: bimodal role explaining longstanding random induction of complete clinical responses

Por Coventry, Brendon J, Ashdown, Martin L
Publicado em 2012

Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation

Por Coventry, Brendon J, Ashdown, Martin L
Publicado em 2012

Mathematical modeling of immune kinetics in advanced cancer through meta-analyses of complete response rates: immune synchronisation emerges as the likely key determinant of clinic...

Por Ashdown, Martin L, Coventry, Brendon J, Abbott, Derek
Publicado em 2013

Clinical outcomes of Interleukin-2 therapy in advanced cancer: meta-analysis of over 62 trials

Por Coventry, Brendon J, Ashdown, Martin L, Bright, Richard
Publicado em 2013

CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?

Por Coventry, Brendon J, Ashdown, Martin L, Quinn, Michael A, Markovic, Svetomir N, Yatomi-Clarke, Steven L, Robinson, Andrew P
Publicado em 2009

Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates

Por Ashdown, Martin L., Robinson, Andrew P., Yatomi-Clarke, Steven L., Ashdown, M. Luisa, Allison, Andrew, Abbott, Derek, Markovic, Svetomir N., Coventry, Brendon J.
Publicado no F1000Res (2015)